Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Development, Exclusivity and Option Products Agreement (Details)

v3.22.2.2
Development, Exclusivity and Option Products Agreement (Details) - USD ($)
6 Months Ended
Jun. 30, 2022
Feb. 28, 2021
Development, Exclusivity and Option Products Agreement [Abstract]    
Upfront cash payment $ 50,000  
Commercial sale milestones   $ 14,000
Proceeds of achievement 36,000  
Option products 53,000  
Non-refundable payment 53,000  
Collateralized agreements 6,000  
Non-refundable payment 4,000  
Additional payable $ 43,000  
Commercial sale 10 years  
Written notice period 60 days